- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinical Experience of <sup>123</sup>I-IMP Scintigraphy in Detecting Vertebral Bone Metastases of Hepatocellular Carcinoma
Bibliographic Information
- Other Title
-
- A Comparison with Bone Scintigraphy with <sup>99m</sup>Tc-MDP
Search this article
Description
<jats:p> Although bone scintigraphy with <jats:sup>99m</jats:sup>Tc-MDP is a sensitive diagnostic method to detect bone metastasis, it is not specific for malignancy. A radioactive substance which accumulates specifically into metastatic lesions should be of value. <jats:sup>123</jats:sup>I-IMP and bone scintigraphy with <jats:sup>99m</jats:sup>Tc-MDP were consecutively performed in patients with vertebral bone metastases from hepatocellular carcinoma and lumbar spondylosis deformans in a 7-day interval or shorter. The intensity of uptake was compared. Eighteen of the 20 metastatic lesions (90%) were classified as increased uptake areas in <jats:sup>123</jats:sup>I-IMP scintigraphy. MDP-scintigraphy disclosed 16 metastatic lesions (80%), 9 as “hot” lesions (56%) and 7 as “cold” lesions (44%). <jats:sup>123</jats:sup>I-IMP scintigraphy was negative in all 12 lesions of lumbar spondylosis deformans. Compared to MDP-scintigraphy, <jats:sup>123</jats:sup>I-IMP scintigraphy was more sensitive in detecting vertebral bone metastases of hepatocellular carcinoma with smaller rates of false-positive and false-negative findings. </jats:p>
Journal
-
- Acta Radiologica
-
Acta Radiologica 35 159-163, 1994-01-01
SAGE Publications